SELLAS Life Sciences Group, Inc. (SLS)
4.58
+0.26
(+6.02%)
USD |
NASDAQ |
Jan 21, 16:00
4.65
+0.07
(+1.53%)
After-Hours: 07:35
SELLAS Life Sciences Group EPS Diluted (Quarterly): -0.0626 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| GT Biopharma, Inc. | -0.8268 |
| Amicus Therapeutics, Inc. | 0.0558 |
| Geron Corp. | -0.0276 |
| Vanda Pharmaceuticals, Inc. | -0.3822 |
| ADMA Biologics, Inc. | 0.1489 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -6.791M |
| Total Expenses (Quarterly) | 6.791M |
| Enterprise Value | 736.07M |
| Earnings Yield | -6.26% |
| Normalized Earnings Yield | -6.264 |